| 000 | 01191 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513203539.0 | ||
| 264 | 0 | _c20000310 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYlisirniö, S | |
| 245 | 0 | 0 |
_aSerum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a5577-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCollagen _xblood |
| 650 | 0 | 4 | _aCollagen Type I |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 |
_aPeptides _xblood |
| 650 | 0 | 4 |
_aProcollagen _xblood |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aSassi, M L | |
| 700 | 1 | _aRisteli, J | |
| 700 | 1 | _aTurpeenniemi-Hujanen, T | |
| 700 | 1 | _aJukkola, A | |
| 773 | 0 |
_tAnticancer research _gvol. 19 _gno. 6C _gp. 5577-81 |
|
| 999 |
_c10651739 _d10651739 |
||